in drug development is based on cell-based and biochemical assays. Although cell-based assays are useful for target validation and ADMET, they are not free from challenges. One of the greatest ...

Dr. Hsu: Cell-based assays provide more biologically relevant information than biochemical assays for high-throughput screening and ADME/Tox. One challenge in developing and validating cell-based ...

This webinar explores innovative methods to discover and qualify KRAS inhibitors with downstream signaling and binding assays, utilizing no-wash HTRF® and AlphaLISA® technology to further the ...

The increase in disease burden, and the corresponding economic burden, has led to the growing use of cell-based assays ... data can be utilized to validate biochemical data and can reveal unknown ...

While cytotoxicity remains a primary effect that drug developers use cell-based assays to quantify, biological activity, biochemical mechanisms and off-target interactions are also being ...

Boston, May 02, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the demand for Cell-Based Assays: Technologies and Global Markets is estimated to increase from $35.3 ...

The investigators envisage that the cell-based S protein assay established in this research would supplement existing pseudovirus and biochemical assays in COVID-19 therapeutic development.

Protein quantification is an indispensable step in a wide range of biochemical and molecular biology applications. Hence, it ...

Our platforms include plate-based screening of cells and biochemical screens. We support both plate reader assays and high content microscopy. All projects are customized to individual project's needs ...